More importantly, intravenous administration of TRH for two weeks significantly improves clinically evaluated cerebellar ataxia in patients with spinocerebellar degeneration [119,120], particularly in lessening dysmetria [115]. This evidence concerns the gene TRH and cerebellar ataxia.